Annual Report and Accounts 2010/11 - Cancer Research UK

Our governance, structure and management
(continued)
Our Trustees 2010/11
The Trustees who served during the year and as at
27 June 2011 are listed below along with biographies.
Michael Pragnell MA (Oxon) MBA (INSEAD)
Chairman
Michael Pragnell (64) is a Non-executive Director of VINCI SA
and a member of the Board of INSEAD. He was founder Chief
Executive Officer of Syngenta AG, based in Switzerland, from
its public listing in 2000 until his retirement at the end of 2007;
he served as Chairman of the Executive Committee and a
member of the Board. He was previously an Executive Director
of AstraZeneca plc, a member of the Supervisory Board of
Advanta BV, a Non-executive Director of David S Smith plc, a
member of the Board of Courtaulds plc as CEO of Courtaulds
Coatings and latterly CFO.
Professor Doctor Anton Berns PhD
Professor Berns (66) is Director of Research and Chairman of
the Board of Directors of the Netherlands Cancer Institute/
Anton van Leeuwenhoek Hospital. He is a member of the
Royal Netherlands Academy of Arts and Sciences and
Secretary General of the European Molecular Biology
Organisation (EMBO). He sits on a number of scientific
advisory boards including CNIO Madrid, Genomic Institute
Singapore, IMP Vienna, WEHI Melbourne and European
Institute of Oncology in Milan. He studied biochemistry at the
University of Nijmegen, receiving his Masters (cum laude) in
1969 and his PhD in 1972. He did his postdoctoral training in
the group of Rudolf Jaenisch at the Salk Institute in La Jolla,
California, where he studied the role of retroviruses in causing
lymphomas in mice.
Professor Adrian Bird CBE FRS FRSE
Professor Bird (63) has held the Buchanan Chair of Genetics at
the University of Edinburgh since 1990 and is Director of the
Wellcome Trust Centre for Cell Biology at the University. His
research concerns epigenetic control of gene expression by
DNA methylation in health and disease. He previously served
as Deputy Chairman of the Wellcome Trust (2007–2010), and
is a Trustee of the Kirkhouse Trust and of the Rett Syndrome
Research Trust. Awards include the Louis-Jeantet Prize for
Medicine and the Charles Léopold Mayer Prize of the French
Academy of Sciences.
Professor Colin Bird CBE FRSE
Professor Bird (73) is a Fellow of the Royal Colleges of
Pathologists, Physicians and Surgeons and of the Academy of
Medical Sciences and the Royal Society of Edinburgh. He was
Chairman and Trustee/Director of onCoreUK until 2011.
He was formerly Dean of Medicine and Provost of Medicine
and Veterinary Medicine at Edinburgh University from
1975–2002 and Professor of Pathology at Leeds (1975–1986)
and Edinburgh (1986–2002) universities. He has longstanding
interests in cancer research, both basic and clinical aspects,
and has worked on these in several universities and research
institutes in the UK and USA.
Dr Philip Campbell BSc MSc DSc FInstP FRAS
Dr Campbell (60) is Editor-in-Chief of Nature and of Nature
publications. He is a Fellow of the Institute of Physics and a
Fellow of the Royal Astronomical Society. He took up his
present position in December 1995 and is also a member
of the Board of Directors of the Nature Publishing Group.
He has advised or collaborated with the Wellcome Trust,
US National Institutes of Health, the UK Office of Science
and Technology and the European Commission on aspects
of the life sciences and their impacts in society.
Sir James Crosby BA FFA
Sir James (55) is Chairman of Misys plc and the Senior
Independent Director of Compass Group plc. He is a member
of the European Advisory Board of Bridgepoint Capital and a
member of the Finance Committee of the Delegacy of Oxford
University Press. He previously served as a Non-executive
Director of ITV (2003–2009) and the Financial Services
Authority (2004–2009) following a 30-year executive career
in fund management, insurance and banking, before retiring
from HBOS in 2006.
Liz Hewitt FCA BSc(Econ) FRSA
Liz Hewitt was Group Director of Corporate Affairs for Smith
& Nephew plc, the global medical technology business, from
2004 to 2011. Liz is a Fellow of the Institute of Chartered
Accountants in England and Wales, having qualified with
Arthur Andersen & Co. She has worked in the venture capital
industry for Gartmore Investment Limited, Citicorp Venture
Capital Limited and 3i Group plc. She has had non-executive
roles with the Rail Users Consultative Committee,
Bournewood NHS Trust, the Audit and Finance Committee
of the Royal Society of Arts, and was Vice-Chairman of the
Surrey Police Authority.
20 / Annual Report and Accounts / Our governance, structure and management